Use of magnetic perfusion-weighted imaging to determine epidermal growth factor receptor variant III expression in glioblastoma

Differentiation between Glioblastomas, Solitary Brain Metastases, and Primary Cerebral Lymphomas Using Diffusion Tensor and Dynamic Susceptibility Contrast-Enhanced MR Imaging

(2011) S. Wang et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

In Vivo Correlation of Tumor Blood Volume and Permeability with Histologic and Molecular Angiogenic Markers in Gliomas

(2010) R. Jain et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

EGFRvIII Antibody-Conjugated Iron Oxide Nanoparticles for Magnetic Resonance Imaging-Guided Convection-Enhanced Delivery and Targeted Therapy of Glioblastoma

(2010) C. G. Hadjipanayis et al.   CANCER RESEARCH

Phase I Trial of Lapatinib in Children With Refractory CNS Malignancies: A Pediatric Brain Tumor Consortium Study

(2010) Maryam Fouladi et al.   JOURNAL OF CLINICAL ONCOLOGY

Use of new imaging techniques to predict tumour response to therapy

(2010) Vanessa N Harry et al.   LANCET ONCOLOGY

Glioblastoma Multiforme Regional Genetic and Cellular Expression Patterns: Influence on Anatomic and Physiologic MR Imaging

(2010) Ramon F. Barajas et al.   RADIOLOGY

EGFRvIII-Targeted Vaccination Therapy of Malignant Glioma

(2009) Bryan D. Choi et al.   BRAIN PATHOLOGY

The EGFRvIII variant in glioblastoma multiforme

(2009) Hui K. Gan et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Randomized Phase II Trial of Erlotinib Versus Temozolomide or Carmustine in Recurrent Glioblastoma: EORTC Brain Tumor Group Study 26034

(2009) Martin J. van den Bent et al.   JOURNAL OF CLINICAL ONCOLOGY

RETRACTED ARTICLE: Glioma grading: sensitivity, specificity, positive and negative predictive values of diffusion and perfusion imaging

(2009) H. R. Arvinda et al.   JOURNAL OF NEURO-ONCOLOGY

Magnetic resonance perfusion-weighted imaging defines angiogenic subtypes of oligodendroglioma according to 1p19q and EGFR status

(2009) Gurpreet S. Kapoor et al.   JOURNAL OF NEURO-ONCOLOGY

The parametric response map is an imaging biomarker for early cancer treatment outcome

(2009) Craig J Galbán et al.   NATURE MEDICINE

The Epidermal Growth Factor Variant III Peptide Vaccine for Treatment of Malignant Gliomas

(2009) Gordon Li et al.   NEUROSURGERY CLINICS OF NORTH AMERICA

Posttreatment Recurrence of Malignant Brain Neoplasm: Accuracy of Relative Cerebral Blood Volume Fraction in Discriminating Low from High Malignant Histologic Volume Fraction

(2009) Emerson L. Gasparetto et al.   RADIOLOGY

Prognostic Value of Perfusion MR Imaging of High-Grade Astrocytomas: Long-Term Follow-Up Study

(2008) T. Hirai et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Development of a Real-time RT-PCR Assay for Detecting EGFRvIII in Glioblastoma Samples

(2008) K. Yoshimoto et al.   CLINICAL CANCER RESEARCH

Targeting the Epidermal Growth Factor Receptor in High-Grade Astrocytomas

(2008) Will R. Voelzke et al.   CURRENT TREATMENT OPTIONS IN ONCOLOGY

Phase I/II Trial of Erlotinib and Temozolomide With Radiation Therapy in the Treatment of Newly Diagnosed Glioblastoma Multiforme: North Central Cancer Treatment Group Study N0177

(2008) Paul D. Brown et al.   JOURNAL OF CLINICAL ONCOLOGY

Evaluation of MR markers that predict survival in patients with newly diagnosed GBM prior to adjuvant therapy

(2008) Suja Saraswathy et al.   JOURNAL OF NEURO-ONCOLOGY

Identification of noninvasive imaging surrogates for brain tumor gene-expression modules

(2008) Maximilian Diehn et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Relationship between Gene Expression and Enhancement in Glioblastoma Multiforme: Exploratory DNA Microarray Analysis

(2008) Whitney B. Pope et al.   RADIOLOGY

Tumor-specific immunotherapy targeting the EGFRvIII mutation in patients with malignant glioma

(2008) John H. Sampson et al.   SEMINARS IN IMMUNOLOGY